lactulose
Trade name: cephulac
Approved
Mar 25, 1976
Lactulose is a non-absorbable sugar used in the treatment of constipation and hepatic encephalopathy. It is administered orally for constipation, and either orally or rectally for hepatic encephalopathy. It generally begins working after 8–12 hours, but may take up to 2 days to improve constipation. — Wikipedia
Clinical trial activity
105 trials · 119 clinical orgs · 26 marketing orgs
Earliest trial started Nov 1, 1994 (NCT00004796)
Timeline
1970s
- Mar 25, 1976
Sanofi-Aventis — Earliest FDA Approval
- Mar 25, 1976
Sanofi-Aventis — NDA Secondary Org
- Mar 25, 1976
Sanofi-Aventis — NDA Organization
1980s
- Jul 26, 1988
Alta Pharma — Marketing Organization
- Aug 15, 1988
Actavis — Marketing Organization
1990s
- May 29, 1992
Roxane Laboratories — Marketing Organization
- May 29, 1992
West-Ward Pharmaceutical — Marketing Organization
- May 29, 1992
Hikma — Marketing Organization
- May 29, 1992
Boehringer Ingelheim — Marketing Organization
- Sep 30, 1992
VistaPharm, Inc. — Marketing Organization
- May 28, 1993
Nostrum Laboratories — Marketing Organization
- May 28, 1993
Teva — Marketing Organization
- Jan 1, 1994
Earliest Phase 2 Sponsor(trial)
- Jul 3, 1995
Hi Tech Pharmaceuticals — Marketing Organization
- Jul 3, 1995
Akorn, Inc. — Marketing Organization
- Jul 30, 1996
Pharmaceutical Associates — Marketing Organization
- Oct 31, 1996
Wockhardt — Marketing Organization
- Dec 10, 1997
Cumberland Pharmaceuticals — Marketing Organization
2000s
- Jul 26, 2001
Lannett Company, Inc. — Marketing Organization
- Feb 21, 2002
Xttrium Laboratories — Marketing Organization
- Feb 21, 2002
Department of Veteran Affairs — Marketing Organization
- Jan 1, 2005
Earliest Phase 3 Sponsor(trial)
- Nov 28, 2007
Ani Pharmaceuticals — Marketing Organization
- Jan 1, 2009
Department of Veteran Affairs — Earliest Phase 1 Sponsor(trial)
2010s
- Jan 25, 2012
Fresenius — Marketing Organization
- Mar 27, 2015
Torrent Pharmaceuticals Limited — Marketing Organization
- Nov 23, 2018
Lifepharma — Marketing Organization
- Nov 23, 2018
Chartwell Pharmaceuticals — Marketing Organization
Indications
Approved for
Studied for
- Acute-On-Chronic Liver Failure · Phase 4
- Bone Diseases, Metabolic · Phase 4
- Burns · Phase 1
- Candidiasis, Vulvovaginal · Phase 3
- Colonoscopy · Phase 4
- Crohn Disease · Early Phase 1
- Dermatitis, Atopic · Phase 2/Phase 3
- Diabetes Mellitus, Type 2 · Phase 4
- Drug-Related Side Effects and Adverse Reactions · Phase 3
- Dyspepsia · Phase 4
- Enterocolitis, Necrotizing · Phase 2
- Fecal Impaction · Phase 2
- Fibrosis · Phase 4
- Fissure in Ano · Phase 4
- Hamartoma · Phase 4
- Hemorrhoids · Phase 4
- Hepatic Encephalopathy · Phase 4
- Hypertension, Portal · Phase 4
- Infant, Premature, Diseases · Phase 1
- Intestinal Diseases · Phase 4
- Intestinal Neoplasms · Phase 1
- Intestines · Phase 4
- Lactulose · Phase 4
- Liver Cirrhosis · Phase 4
- Liver Diseases · Phase 4
- Ondansetron · Phase 4
- Pathologic Processes · Phase 4
- Persian Gulf Syndrome · Phase 1
- Renal Insufficiency · Phase 4
- Sepsis · Phase 2
- Treatment Outcome · Phase 3
- Trematode Infections · Phase 4
- Vaginosis, Bacterial · Phase 2/Phase 3
Mechanism of action
- Unspecified targetUnclear
Unclear
Increases water content in the colon
Approval history
- approvedPriority reviewMar 25, 1976
Chemistry & pharmacology
SMILES
O.OC[C@H]1O[C@@H](O[C@@H]2[C@@H](CO)O[C@](O)(CO)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O- Mol. weight
- 360.31 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Availability
- Prescription Only
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaLactulose ↗
- ChEMBLCHEMBL1237068 ↗
Also known as
- 4-o-beta-d-galactopyranosyl-d-fructofuranose
- 4-o-beta-d-galactopyranosyl-d-fructofuranose
- 4-o-beta-d-galactopyranosyl-d-fructose
- 4-o-beta-d-galactopyranosyl-d-fructose
- acilac
- acilac
- bifiteral
- bifiteral
- bifiteral
- cephulac
- cephulac
- cephulac
- cephulac
- cholac
- cholac
- chronulac
- chronulac
- constilac
- constilac
- constulose
- constulose
- crystalline lactulose
- d-lactulose
- duphalac
- duphalac
- duphalac dry
- enulose
- enulose
- evalose
- evalose
- generlac
- generlac
- heptalac
- heptalac
- isolactose
- lactulone
- lactulosa
- lactulosa
- lactulose
- lactulose
- lactulose
- lactulose
- lactulose
- lactulose
- lactulose
- lactulose
- lactulose
- lactulose
- lactulose
- lactulose hydrate
- lactulose hydrate
- lactulose hydrate
- lactulosum
- lactulosum
- lattulose
- laxilose
- laxilose
- laxose orange
- lemlax
- osmolax
- portalac
- portalac
- regulose
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07273734 | N/A | Jan 1, 2026 | Chongqing Medical University, Kunming Medical University, Sichuan University |
| NCT06995586 | N/A | Sep 1, 2025 | Cyprus University of Technology, Government of Russia, University of Cyprus |
| NCT07084350 | N/A | Aug 25, 2025 | People's Liberation Army of China |
| NCT07060222 | Phase 4 | Jul 20, 2025 | University of Guadalajara |
| NCT07002827 | N/A | May 30, 2025 | Institute of Liver and Biliary Sciences, India |
| NCT06808009 | N/A | Feb 5, 2025 | Institute of Liver and Biliary Sciences, India |
| NCT06802042 | N/A | Jan 9, 2025 | Chinese Academy of Medical Sciences |
| NCT07037394 | Phase 4 | Dec 2, 2024 | Islamia University of Bahawalpur |
| NCT06483737 | N/A | Oct 1, 2024 | People's Liberation Army of China |
| NCT06748638 | Phase 4 | Sep 1, 2024 | Jinlin University, Nanjing Medical University |
| NCT06538077 | N/A | Aug 31, 2024 | Indian Council of Medical Research, Postgraduate Institute of Medical Education and Research |
| NCT06835361 | Phase 2/Phase 3 (Phase 3) | Feb 29, 2024 | Government of Russia |
| NCT05794555 | Phase 3 | Jun 13, 2023 | Patient-Centered Outcomes Research Institute, University of Michigan, University of Pennsylvania |
| NCT05788627 | Phase 4 | Apr 30, 2023 | Khyber Medical University Peshawar |
| NCT05878639 | N/A | Mar 28, 2023 | Wenzhou Medical University |
| NCT05726344 | N/A | Feb 10, 2023 | Hospital de Clínicas Dr. Manuel Quintela |
| NCT05700695 | Phase 1 | Jan 17, 2023 | All India Institute of Medical Sciences, Amrita Institute of Medical Sciences, Asian Institute of Gastroenterology, Kalinga Institute of Medical Sciences, Bhubaneswar, Postgraduate Institute of Medical Education and Research |
| NCT06411314 | Phase 3 | Dec 29, 2022 | Avva Rus, JSC |
| NCT05498714 | N/A | Jul 18, 2022 | Wuhan University |
| NCT05341180 | Phase 2/Phase 3 (Phase 3) | May 27, 2022 | All India Institute of Medical Sciences |
Organizations
Research & Development (119)
Marketing (29)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Actavis | For profit | MKTG | Aug 15, 1988 |
| Akorn, Inc. | For profit | MKTG | Jul 3, 1995 |
| Alta Pharma | For profit | MKTG | Jul 26, 1988 |
| Ani Pharmaceuticals | For profit | MKTG | Nov 28, 2007 |
| Boehringer Ingelheim | For profit | MKTG | May 29, 1992 |
| Chartwell Pharmaceuticals | For profit | MKTG | Nov 23, 2018 |
| Cumberland Pharmaceuticals | For profit | MKTG | Dec 10, 1997 |
| Department of Veteran Affairs | Government | MKTG | Feb 21, 2002 |
| Fresenius | For profit | MKTG | Jan 25, 2012 |
| Hi Tech Pharmaceuticals | For profit | MKTG | Jul 3, 1995 |
| Hikma | For profit | MKTG | May 29, 1992 |
| Hikma | For profit | SYN | May 29, 1992 |
| Lannett Company, Inc. | For profit | MKTG | Jul 26, 2001 |
| Lifepharma | For profit | MKTG | Nov 23, 2018 |
| Morton Grove Pharmaceuticals | For profit | MKTG | — |
| Nostrum Laboratories | For profit | MKTG | May 28, 1993 |
| Paco | For profit | MKTG | — |
| Pharmaceutical Associates | For profit | MKTG | Jul 30, 1996 |
| Roxane Laboratories | For profit | MKTG | May 29, 1992 |
| Sanofi-Aventis | For profit | NDA2 | Mar 25, 1976 |
| Sanofi-Aventis | For profit | NDA | Mar 25, 1976 |
| Solvay | For profit | NDA2 | — |
| Solvay | For profit | MKTG | — |
| Teva | For profit | MKTG | May 28, 1993 |
| Torrent Pharmaceuticals Limited | For profit | MKTG | Mar 27, 2015 |
| VistaPharm, Inc. | For profit | MKTG | Sep 30, 1992 |
| West-Ward Pharmaceutical | For profit | MKTG | May 29, 1992 |
| Wockhardt | For profit | MKTG | Oct 31, 1996 |
| Xttrium Laboratories | For profit | MKTG | Feb 21, 2002 |